UK Companies House feature
TEVA NI LIMITED
Profile
- Company number
- NI023272
- Status
- Active
- Incorporation
- 1989-11-14
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors believe that preparing the financial statements on a going concern basis is appropriate due to the continued financial support of Teva Pharmaceuticals Europe B.V., a fellow group company. The directors have received confirmation from Teva Pharmaceuticals Europe B.V. that it has pledged its continuing support for a minimum on 12 months from the date of signing these financial statements.”
Significant events
- “The company's previous subsidiary holding, Teva Pharma UK Limited, was dissolved on 2 December 2024.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| COOPER, Dean Michael | Director | 2021-07-01 | Sep 1972 | British |
| GARVIN, David Harold James | Director | 2021-07-01 | Feb 1964 | British |
| MULDOON, Brendan Christopher Oliver | Director | 2016-04-08 | Sep 1976 | Irish |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ELLIOTT, Geoffrey | Secretary | 1989-11-14 | 2005-01-05 |
| WHITFORD, Robert | Secretary | 2005-02-02 | 2016-04-08 |
| PINSENT MASONS SECRETARIAL LIMITED | Corporate Secretary | 2017-03-13 | 2017-03-13 |
| BOISSONNEAULT, Roger | Director | 2007-01-09 | 2011-09-30 |
| CHARLESWORTH, Stephen Michael | Director | 2020-04-29 | 2021-07-01 |
| CHESTNUTT, Peter Vincent | Director | 2018-06-13 | 2021-07-01 |
| COOPER, Dean Michael | Director | 2018-07-12 | 2020-04-29 |
| COULTER, Cathy | Director | 2011-01-20 | 2013-11-01 |
| ELLIOTT, Geoffrey | Director | 2001-09-30 | 2005-01-05 |
| GILLIGAN, Claire, Dr | Director | 2005-02-02 | 2016-04-08 |
| HEALEY, Peter David | Director | 2010-03-30 | 2010-10-21 |
| KING, John A | Director | 1989-11-14 | 2005-01-05 |
| MCCLAY, Allen James, Dr | Director | 1989-11-14 | 2001-10-04 |
| MCILROY, James William, Dr | Director | 2016-04-08 | 2018-03-14 |
| WHITFORD, Robert | Director | 2005-01-05 | 2016-04-08 |
| WILLIAMS, Robert | Director | 2016-08-02 | 2018-06-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Teva Milbrook Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 165 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-09-25 | AA | accounts | accounts with accounts type full |
| 2025-05-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-10-03 | AA | accounts | accounts with accounts type full |
| 2024-05-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-01-02 | AA | accounts | accounts with accounts type full |
| 2023-05-09 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-12-09 | AA | accounts | accounts with accounts type full |
| 2022-05-09 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-10-04 | AA | accounts | accounts with accounts type full |
| 2021-07-07 | AP01 | officers | appoint person director company with name date |
| 2021-07-07 | AP01 | officers | appoint person director company with name date |
| 2021-07-07 | TM01 | officers | termination director company with name termination date |
| 2021-07-07 | TM01 | officers | termination director company with name termination date |
| 2021-05-24 | CS01 | confirmation-statement | confirmation statement with updates |
| 2021-03-16 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2020-11-10 | AA | accounts | accounts with accounts type full |
| 2020-05-12 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-04-29 | TM01 | officers | termination director company with name termination date |
| 2020-04-29 | AP01 | officers | appoint person director company with name date |
| 2019-10-03 | AA | accounts | accounts with accounts type full |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Composite activity score · components 0–100 · reference 2026-05-10
17.1
COLD
/ 100
- Filings velocity 8
- Capital events 0
- Officer churn 0
- Headcount trajectory 50
- Accounts trajectory 50
- 1 filing(s) in last 12 months